Type 2 deiodinase Thr92Ala polymorphism impact on clinical course and myocardial remodeling in patients with Graves' disease

Cell Cycle

Volumn 8, Issue 16, 2009, Pages 2565-2569

  Grineva, Elena ^b   Babenko, Alina ^a   Vahrameeva, Natalya ^b   Bogdanova, Maria ^c   Kostareva, Anna ^a   Popcova, Daria ^a   Larionova, Valentina ^c  

^a ALMAZOV NATIONAL MEDICAL RESEARCH CENTRE   (Russian Federation)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^c SAINT PETERSBURG STATE PEDIATRIC MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Graves' disease; Myocardial remodeling; Thr92Ala polymorphism D2 gene; Thyrotoxicosis; Type 2 deiodinase

Indexed keywords

DEIODINASE 2; LIOTHYRONINE; SELENOPROTEIN; THYROID PEROXIDASE; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOMYOPATHY; ECHOCARDIOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GRAVES DISEASE; HEART MUSCLE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL;

EID: 69249203789     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.16.9250     Document Type: Article

References (17)

1. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002; 23:38-89. (Pubitemid 34185306)
2. Kohrle J. Local activation and inactivation of thyroid hormones: the deiodinase family. Mol Cell Endocrinol 1999; 151:103-119 (Pubitemid 29295518)
3. Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuiper GGJM, Uitterlinden AG, et al. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab 2003; 88:2880-2888 (Pubitemid 36724470)
4. Peeters RP, van der Deure VM, Visser TJ. Genetic variation in thyroid hormone pathway genes; polymorphisms in the TSH receptor and the iodothyronine deiodinases. Eur J Endocrinol 2006; 155:655-662
5. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR. Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest 2005; 115:2524-2533
6. Nicoloff JT, Lum SM, Spencer CA, Morris R. Peripheral autoregulation of thyroxine to triiodothyronine conversion in man. Horm Metab Res Suppl 1984; 14:74-79
7. Pilo A, Iervasi G, Vitek F, Ferdeghini M, Cazzuola F, Bianchi R. Thyroidal and peripheral production of 3,5,3′-triiodothyronine in humans by multicompartmental analysis. Am J Physiol 1990; 258:715-726
8. Salvatore D, Tu H, Harney JW, Larsen PR. Type 2 iodothyronine deiodinase is highly expressed in human thyroid. J Clin Invest 1996; 98:962-968 (Pubitemid 26293314)
9. Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Saccà L, et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 2000; 85:4701-4705 (Pubitemid 32157655)
10. Pachucki J, Hopkins J, Peeters R, Tu H, Carvalho SD, Kaulbach H, et al. Type 2 iodothyronine deiodinase transgene expression in the mouse heart causes cardiac-specific thyrotoxicosis. Endocrinology 2001; 142:13-20. (Pubitemid 32183660)
11. Trivieri MG, Oudit GY, Sah R, Kerfant BG, Sun H, Gramolini AO, et al. Cardiacspecific elevation in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. Proc Natl Acad Sci USA 2006; 103:6043-6048
12. Canani LH, Capp C, Dora JM, Souza Meyer EL, Wagner MS, Harney JW, et al. The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2005; 90:3472-3478 (Pubitemid 41014316)
13. Guo TW, Zhang FS, Yang MS, Gao XC, Bian L, Duan SW, et al. Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of China. J Med Gen 2004; 41:585-590
14. Mentuccia D, Proietti-Pannunzi L, Tanner K, Bacci V, Pollin TI, Poehlman ET, et al. Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance. Diabetes 2002; 51:880-883
15. Gumieniak O, Perlstein TS, Williams JS, Hopkins PN, Brown NJ, Raby BA, et al. Ala92 type 2 deiodinase allele increases risk for the development of hypertension. Hypertension 2007; 49:461-466 (Pubitemid 46263228)
16. Maia AL, Hwang SJ, Levy D, Larsen PR, Larson MG, Fox CS. Lack of association between the type 2 deiodinase A/G polymorphism and hypertensive traits: The Framingham Heart Study. Hypertension 2008; 51:22-23 (Pubitemid 351654710)
17. Canani LH, Leie MA, Machado WE, Capp C, Maia AL. Type 2 deiodinase Thr92Ala polymorphism is not associated with arterial hypertension in type 2 diabetes mellitus patients. Hypertension 2007; 49:461-466 (Pubitemid 46809405)